Reading GL? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GL free→Reading GL? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GL free→
NYSEFinancialsInsurance - LifeSnapshot 2026-06-16
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is neutral, and earnings quality is also neutral. Management's recent track record has been fairly steady, but the capital stance is capital unfriendly. Risk is low, while the sector backdrop is a headwind, indicating challenges in the current environment. Peer multiples imply a price about 19% above where it trades (it looks cheap on this basis); the read is fair. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 8 valuation methods, at three horizons. Current price $169.20. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $167 GL trades at 11× p/e, below its 14× p/e peer median. Our $210 fair value sits above the price; medium confidence. Analysts: $157–$185. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 20% below a flat-multiple fair value, below our forecast of about 8%. This describes what's priced in, not a forecast of the move.
Only weak execution quality, a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Financials names rated neutral grew net income 52% of the time over the next year (vs 61% for the rest of the cohort, n=4936).
Over the trailing year it converted 1.18x of net income into operating cash flow. Historically, Financials names rated neutral grew net income 58% of the time over the next year (vs 55% for the rest of the cohort, n=4725).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $3.68 → $3.68 (+0.0% / 30d). 3 raised, 1 cut, 8 covering analysts.
0 upgrades, 0 downgrades / 30d, 2 maintained. 73% of analysts rate Buy.
2 PT revisions / 30d. Avg target 14.3% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$90.
How much price usually moves either way.
On a bad day, this stock has moved -$174.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $1,087.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Growth in net operating income shows strong operations. This can make investors feel more positive.
Confirms:Q2 net operating income increases year over year by more than 10%.
Disproves:Q2 net operating income decreases year over year.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
Advances: Increase EPS guidance for 2026
Raised guidance directly supports EPS growth objective.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Other Officers. (a) Not applicable. (b) Linda L. Addison and Marilyn A. Alexander retired from the Globe Life Inc. Board of Directors at the Annual Meeting of Shareholders on April 30, 2026. (c) Not applicable. (d) Not applicable. (e) Not applicable.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$157.00 – $185.00 (median $178.00) · 4 analysts · as of 2026-05-26
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Life & Health Insurance.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
GL Globe Life | Above typical Show detailsSector percentile: 94 of 100 | fair | low |
AFL Aflac | Below typical Show detailsSector percentile: 23 of 100 | full | moderate |
MET MetLife | Above typical Show detailsSector percentile: 88 of 100 | inexpensive | moderate |
PRU Prudential Financial | Above typical Show detailsSector percentile: 92 of 100 | inexpensive | low |
PFG Principal Financial Group | Typical Show detailsSector percentile: 60 of 100 | fair | low |
13 material management or governance events in the past 24 months, led by executive changes. Historically, Financials names rated neutral grew net income 57% of the time over the next year (vs 55% for the rest of the cohort, n=5004).
Not investment advice. As of 2026-06-16.
via XLF
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Globe Life aims to increase its full-year 2026 earnings guidance to a range of $15.40 to $15.90 per share.
Globe Life continues its share repurchase program, buying back 1.4 million shares in the latest quarter.
Globe Life focuses on increasing net sales in both life and health insurance segments.
Why it matters: An increase in earnings guidance would show strong business momentum and confidence.
Confirms:Management raises 2026 earnings guidance to over $15.90 per share.
Disproves:Management lowers 2026 earnings guidance to below $15.40 per share.
Why it matters: More share buybacks can raise earnings per share. This shows management's confidence.
Confirms:The company buys back over 1.5 million shares in one quarter.
Disproves:No share repurchases or a decrease in the number of shares repurchased.
Why it matters: An increase in agents typically leads to higher sales and revenue growth.
Confirms:The average number of producing agents goes up by more than 5% every quarter.
Disproves:The average number of producing agents falls or stays the same each quarter.
Why it matters: Strong sales growth shows demand. It also means good sales strategies for future earnings.
Confirms:Life and health net sales increase by more than 10% year over year.
Disproves:Life and health net sales growth falls below 5% year over year.
Results of Operations and Financial Condition. On April 22, 2026, Globe Life Inc. issued a press release announcing its first quarter 2026 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Excha…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Other Officers. (d) On February 25, 2026, pursuant to the By-Laws of Globe Life Inc. (the "Company"), the Board of Directors (the "Board") of the Company voted to expand the number of directors from twelve to fourteen persons as of such date, and appointed Derek T. Kan and Sandra L. Phillips to fill the newly-created directorships. Mr. Kan and Ms. Phillips will each…
Results of Operations and Financial Condition. On February 4, 2026, Globe Life Inc. issued a press release announcing its fourth quarter 2025 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Ex…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 5, 2025, Globe Life Inc. (the “Company”) entered into an Amendment One (the “Amendment”) to the Globe Life Inc. Supplemental Executive Retirement Plan (the “SERP”). The Amendment: • Revises the early retirement reduction factor for reducing the amount of benefit payable under the SERP when participants retire before the age of 65 as set…